Table 1.
Questionnaire items | Replies | All HoFH | Patients lost access to LA session due to COVID-19 pandemic |
||
---|---|---|---|---|---|
All group | No additional new-generation LLT use | Additional new-generation LLT use | |||
N | 34 | 14 | 7 | 7 | |
Any complaint, n (%) | - | 3 (8.8) | 1 (7.1) | 1 (14.3) | 0 |
Use of medicines regularly, n (%) | - | 30 (88.2) | 12 (85.7) | 5 (71.4) | 7 (100) |
Working during the epidemic, n (%) |
|
1 (2.9) 3 (8.8) 30 (88.2) |
0 0 14 (100) |
0 0 7 (100) |
0 0 7 (100) |
Increase in anxiety, n (%) | - | 21 (61.8) | 9 (64.3) | 6 (85.7) | 3 (42.9) |
Anxiety level, ∗ mean ± SD (minimum–maximum) | - | 4.79 ± 2.57 (0-9) | 4.93 ± 2.26 (2-8) | 5.14 ± 2.12 (2-8) | 4.71 ± 2.56 (2-8) |
Sleep, n (%) |
|
6 (17.6) 6 (17.6) 22 (64.7) |
3 (21.4) 2 (14.3) 9 (64.3) |
2 (28.6) 1 (14.3) 4 (57.1) |
1 (14.3) 1 (14.3) 5 (71.4) |
Appetite, n (%) |
|
5 (14.7) 8 (23.5) 21 (61.8) |
4 (28.6) 1 (7.1) 9 (64.3) |
3 (42.9) 0 4 (57.1) |
1 (14.3) 1 (14.3) 5 (71.4) |
Dietary compliance, n (%) |
|
20 (58.8) 5 (14.7) 9 (26.5) |
9 (64.3) 0 5 (35.7) |
5 (71.4) 0 2 (14.3) |
4 (57.1) 0 3 (42.9) |
Exercise habits, n (%) |
|
8 (23.5) 17 (50) 9 (26.5) |
4 (28.6) 7 (50) 3 (21.4) |
2 (28.6) 3 (42.9) 2 (66.7) |
2 (28.6) 4 (57.1) 1 (14.3) |
Smoking, n (%) |
|
27 (79.4) 1 (2.9) 4 (11.8) 2 (5.9) |
12 (85.7) 0 2 (14.3) 0 |
6 (85.7) 0 1 (14.3) 0 |
6 (85.7) 0 1 (14.3) 0 |
Thought of increased vulnerability within the course of COVID-19 due to underlying FH, n (%) |
|
27 (79.4) 5 (14.7) 2 (5.9) |
11 (78.6) 2 (14.3) 1 (7.1) |
7 (100) 0 0 |
4 (57.1) 2 (28.6) 1 (14.3) |
Have admitted to a hospital during the pandemic? n (%) | - | 9 (26.5) | 3 (21.4) | 0 | 3 (42.9) |
Would admit to a hospital due to a complaint, n (%) | - | 9 (26.5) | 2 (14.3) | 0 | 2 (14.3) |
FH, familial hypercholesterolemia; LA, LDL apheresis; LLT, lipid-lowering therapy; SD, standard deviation.
The anxiety level for all samples has a skewed distribution; the median level is 5.